Skip to main content

Table 2 Comparison of CARDS toxin and cytokines in BALF from control and MPP (including RMPP and NRMPP) children

From: High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia

CARDS toxin and cytokines in BALF

MPP cases

(n = 71)

Controls

(n = 22)

P value

RMPP

(n = 21)

NRMPP

(n = 50)

P value

CARDS toxin, relative expression

12.5 (4.9–31.1)

0.5 (0.2–1.4)

< 0.001

19.6 (9.0–63.0)

10.0 (3.1–25.5)

0.025

TNF-α, pg/ml

68 ± 12.7

40.4 ± 6.2

< 0.001

76.9 ± 11.2

64.2 ± 11.4

< 0.001

IFN-γ, pg/ml

541.2 ± 104.1

357.3 ± 83.3

< 0.001

535.6 ± 96.9

543.5 ± 104.8

0.772

IL-36, pg/ml

429.9 ± 60.6

360.5 ± 61.2

< 0.001

438.8 ± 61.6

426.5 ± 60.5

0.457

IL-17, pg/ml

23.6 ± 5.6

24.7 ± 5.4

0.428

23.6 ± 5.4

23.6 ± 5.8

0.986

IL-8, pg/ml

67 ± 15.0

52.2 ± 14.7

< 0.001

65.4 ± 14.7

67.7 ± 15.2

0.584

IL-6, pg/ml

24.7 ± 5.7

16.1 ± 4.0

< 0.001

28.1 ± 3.8

23.2 ± 5.8

< 0.001

IL-4, pg/ml

66.8 ± 14.6

36.4 ± 6.5

< 0.001

68.7 ± 12.5

66.0 ± 15.4

0.477

  1. RMP refractory Mycoplasma pneumoniae pneumonia, NRMPP non-refractory Mycoplasma pneumoniae pneumonia, CARDS toxin community-acquired respiratory distress syndrometoxin, BALF bronchoalveolar lavage fluid, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, IL-36 interleukin-36, IL-17 interleukin-17, IL-8 interleukin-8, IL-6 interleukin-6, IL-4 interleukin-4